AGIO Earnings Agios Pharmaceuticals, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -1.69 | 2026-07-30 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.69 | 2026-04-29 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -1.86 | 2026-02-12 | 10-K |
| FY 2025 | 2025-12-31 | -7.12 | 2026-02-12 | 10-K |
| Q3 2025 | 2025-09-30 | -1.78 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.93 | 2025-07-31 | 10-Q |
| Q1 2025 | 2025-03-31 | -1.55 | 2025-05-01 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -1.44 | 2025-02-13 | 10-K |
| FY 2024 | 2024-12-31 | 11.64 | 2025-02-13 | 10-K |
| Q3 2024 | 2024-09-30 | 16.22 | 2024-10-31 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.69 | 2024-08-01 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.45 | 2024-05-02 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1.71 | 2024-02-15 | 10-K |
| FY 2023 | 2023-12-31 | -6.33 | 2024-02-15 | 10-K |
| Q3 2023 | 2023-09-30 | -1.64 | 2023-11-02 | 10-Q |
| Q2 2023 | 2023-06-30 | -1.51 | 2023-08-03 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.47 | 2023-05-04 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 0.68 | 2023-02-23 | 10-K |
| FY 2022 | 2022-12-31 | -4.23 | 2023-02-23 | 10-K |
| Q3 2022 | 2022-09-30 | -1.49 | 2022-11-03 | 10-Q |
| Q2 2022 | 2022-06-30 | -1.68 | 2022-08-04 | 10-Q |
| Q1 2022 | 2022-03-31 | -1.74 | 2022-05-05 | 10-Q |
| Q4 2021 | 2021-12-31 | -1.74 | 2022-02-24 | 10-K |
| FY 2021 | 2021-12-31 | 26.55 | 2022-02-24 | 10-K |
| Q3 2021 | 2021-09-30 | -1.56 | 2021-11-03 | 10-Q |
| Q2 2021 | 2021-06-30 | -1.41 | 2021-07-29 | 10-Q |
| Q1 2021 | 2021-03-31 | 26.95 | 2021-04-29 | 10-Q |
| Q4 2020 | 2020-12-31 | -1.41 | — | — |
| FY 2020 | 2020-12-31 | -4.74 | — | — |
| Q3 2020 | 2020-09-30 | -1.43 | — | — |
| Q2 2020 | 2020-06-30 | -1.31 | — | — |
| Q1 2020 | 2020-03-31 | -0.59 | — | — |
| FY 2019 | 2019-12-31 | -6.86 | — | — |
| Q3 2015 | 2015-09-30 | -1.07 | 2015-11-06 | 10-Q |
| Q4 2014 | 2014-12-31 | -0.76 | 2015-02-24 | 10-K |
| Q3 2014 | 2014-09-30 | 0.10 | 2014-11-07 | 10-Q |
| Q2 2015 | 2014-06-30 | -0.54 | — | — |
| Q1 2015 | 2014-03-31 | -0.39 | — | — |
| Q3 2013 | 2013-09-30 | -0.52 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.